Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway - PubMed (original) (raw)
Potentiation of NK cell-mediated cytotoxicity in human lung adenocarcinoma: role of NKG2D-dependent pathway
Béatrice Le Maux Chansac et al. Int Immunol. 2008 Jul.
Abstract
Natural cytotoxicity receptors and NKG2D correspond to major activating receptors involved in triggering of tumor cell lysis by human NK cells. In this report, we investigated the expression of NKG2D ligands (NKG2DLs), MHC class I-related chain (MIC) A, MICB and UL16-binding proteins 1, 2 and 3, on a panel of human non-small-cell lung carcinoma cell lines, and we analyzed their role in tumor cell susceptibility to NK cell lysis. Although adenocarcinoma (ADC) cells expressed heterogeneous levels of NKG2DLs, they were often resistant to NK cell-mediated killing. Resistance of a selected cell line, ADC-Coco, to allogeneic polyclonal NK cells and autologous NK cell clones correlated with shedding of NKG2DLs resulting from a matrix metalloproteinase (MMP) production. Treatment of ADC-Coco cells with a MMP inhibitor (MMPI) combined with IL-15 stimulation of autologous NK cell clones lead to a potentiation of NK cell-mediated cytotoxicity. This lysis is mainly NKG2D mediated, since it is abrogated by anti-NKG2D-neutralizing mAb. These results suggest that MMPIs, in combination with IL-15, may be useful for overcoming tumor cell escape from the innate immune response.
Similar articles
- Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, Moretta A. Pende D, et al. Cancer Res. 2002 Nov 1;62(21):6178-86. Cancer Res. 2002. PMID: 12414645 - [Expression of NKG2D ligands in multidrug-resistant nasopharyngeal carcinoma cell line CNE2/DDP and their effects on cytotoxicity of natural killer cells].
Mei JZ, Guo KY, Wei HM, Song CY. Mei JZ, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2007 Jun;27(6):887-9. Nan Fang Yi Ke Da Xue Xue Bao. 2007. PMID: 17584663 Chinese. - Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition.
Wrobel P, Shojaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff H, Kabelitz D, Wesch D. Wrobel P, et al. Scand J Immunol. 2007 Aug-Sep;66(2-3):320-8. doi: 10.1111/j.1365-3083.2007.01963.x. Scand J Immunol. 2007. PMID: 17635809 - Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.
Zwirner NW, Fuertes MB, Girart MV, Domaica CI, Rossi LE. Zwirner NW, et al. Cytokine Growth Factor Rev. 2007 Feb-Apr;18(1-2):159-70. doi: 10.1016/j.cytogfr.2007.01.013. Epub 2007 Feb 26. Cytokine Growth Factor Rev. 2007. PMID: 17324607 Review. - NKG2D ligands: key targets of the immune response.
González S, López-Soto A, Suarez-Alvarez B, López-Vázquez A, López-Larrea C. González S, et al. Trends Immunol. 2008 Aug;29(8):397-403. doi: 10.1016/j.it.2008.04.007. Epub 2008 Jul 3. Trends Immunol. 2008. PMID: 18602338 Review.
Cited by
- TIMP1 and TIMP2 Downregulate TGFβ Induced Decidual-like Phenotype in Natural Killer Cells.
Albini A, Gallazzi M, Palano MT, Carlini V, Ricotta R, Bruno A, Stetler-Stevenson WG, Noonan DM. Albini A, et al. Cancers (Basel). 2021 Oct 1;13(19):4955. doi: 10.3390/cancers13194955. Cancers (Basel). 2021. PMID: 34638439 Free PMC article. - Leveraging NKG2D Ligands in Immuno-Oncology.
Fuertes MB, Domaica CI, Zwirner NW. Fuertes MB, et al. Front Immunol. 2021 Jul 29;12:713158. doi: 10.3389/fimmu.2021.713158. eCollection 2021. Front Immunol. 2021. PMID: 34394116 Free PMC article. Review. - Low RECK Expression Is Part of the Cervical Carcinogenesis Mechanisms.
Herbster S, Trombetta-Lima M, de Souza-Santos PT, Paladino A, Silveira CRF, Sogayar MC, Villa LL, Lepique AP, Boccardo E. Herbster S, et al. Cancers (Basel). 2021 May 6;13(9):2217. doi: 10.3390/cancers13092217. Cancers (Basel). 2021. PMID: 34066355 Free PMC article. - Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function.
Rossi GR, Trindade ES, Souza-Fonseca-Guimaraes F. Rossi GR, et al. Front Immunol. 2020 Jan 29;11:73. doi: 10.3389/fimmu.2020.00073. eCollection 2020. Front Immunol. 2020. PMID: 32063906 Free PMC article. Review. - Role of NKG2D and its ligands in cancer immunotherapy.
Liu H, Wang S, Xin J, Wang J, Yao C, Zhang Z. Liu H, et al. Am J Cancer Res. 2019 Oct 1;9(10):2064-2078. eCollection 2019. Am J Cancer Res. 2019. PMID: 31720075 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials